Daily
coffee may help reduce beta amyloid levels -- plaque accumulation in the brain
-- as a means to prevent, treat and slow the progression of Alzheimer's
disease, finds promising research by a team led by an Indian-origin scientist.
To
say that strategising medicines to treat Alzheimer's disorders is important is
an understatement. "Moreover, to say that caffeine is just an ordinary
staple in our lives, whether caffeine is part of coffee or a chocolate bar, is
also an understatement," said Patricia A Broderick, editor-in-chief of the
Journal of Caffeine Research that published the study.
In
the article "Caffeine as Treatment for Alzheimer's: A Review",
Abhishek Mohan from Old Dominion University in Norfolk, Virginia and co-authors
identified the potential opportunities for using caffeine to reduce beta
amyloid levels.
Mohan
and his team found that the proposed link between caffeine and reductions in
the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD)
suggest a possible role for caffeine in AD treatment.
"Thus,
what Mohan has published herein is elegant in its simplicity; his work is critically
on target," added Broderick, also adjunct professor in neurology at New
York University.
No comments:
Post a Comment